Undisclosed Neuroplastogen Programs

About Psilera Bioscience

Psilera Bioscience is a private, preclinical-stage biotech pioneering a new class of serotonergic compounds termed neuroplastogens for neurological and psychiatric conditions. Leveraging a proprietary library of over one million novel compounds and a leadership team with deep industry experience, the company is building a pipeline of non-hallucinogenic and short-duration psychedelic-inspired therapeutics. Its strategy focuses on creating first-in-class drugs with improved safety and accessibility profiles compared to classical psychedelics, targeting significant unmet needs in mental health.

Therapeutic Areas